NoPrescriptionDrugstore.com Order Status FAQ Online Drugstore Affiliate Program Contact NoPrescriptionDrugstore.com No Prescription Drugs Newsletter Refer a Friend
 
Thursday, June 19, 2008  
REVLIMID(R) Data For Newly Diagnosed Multiple Myeloma Reported At A Satellite Symposium During The 13th European Hematology Association Congress (No Prescription)
REVLIMID(R) Data For Newly Diagnosed Multiple Myeloma Reported At A Satellite Symposium During The 13th European Hematology Association Congress
Data from the ECOG E4A03 and SWOG 0232 studies were reported at a Satellite Symposium and showed that newly diagnosed multiple myeloma patients who are eligible for a transplant, obtain better outcomes when treated with REVLIMID (lenalidomide) plus dexamethasone. The data were presented by Dr A.
Source: www.medicalnewstoday.com

Department Of Health Awards Contract For HPV Vaccine
The contract to provide the vaccine against HPV (human papillomavirus), was awarded by the Department of Health to pharmaceutical company GlaxoSmithKline for their vaccine 'Cervarix'. The contract is to supply the vaccine that protects against cervical cancer and pre-cancerous cell changes in the cervix caused by HPV viruses.
Source: www.medicalnewstoday.com

Individualized Therapies For Non-Hodgkin's Lymphoma
Positron emission tomography (PET) could be an important tool for identifying non-Hodgkin's lymphoma patients who are likely to respond well to treatment with 90 ibritumomab tiuxetan (IT) - the first radioimmunotherapy treatment approved for use by the U.S. Food and Drug Administration, said researchers at SNM's 55th Annual Meeting.
Source: www.medicalnewstoday.com

Maqui Superberry: The Highest Antioxidant Superfruit Is Now Available In The United States!
Novelle International has launched Maqui Superberry, a breakthrough product in the fast-moving superfruit market! Maqui Superberry liquid supplement has the highest antioxidant value of any known superfruit based liquid supplement; with an ORAC value 4 to 30 times higher than the average Acai, Goji Berry, Pomegranate, Noni and Mangosteen products.
Source: www.medicalnewstoday.com

Alfuzosin Stone Expulsion Therapy For Distal Ureteral Calculi: A Double-Blind Placebo-Controlled Study
ORLANDO, FL (UroToday.com) - Medical expulsive therapy for the management of distal ureteral calculi has been shown in several randomized controlled trials to decrease the time to stone expulsion and to increase the stone passage rate.
Source: www.medicalnewstoday.com

New Test Makes Cheating With Drugs In Sports Easier To Detect - Research News From Journal Of Mass Spectrometry
A new mass spectrometry test can help sports anti-drug doping officials to detect whether an athlete has used drugs that boost naturally occurring steroid levels. The test is more sensitive compared to previous alternatives, more capable of revealing specific suspicious chemical in the body, faster to perform, and could be run on standard drug-screening laboratory equipment.
Source: www.medicalnewstoday.com

Absence Of Viable Carcinoma In Biopsies Performed Greater Than 1-Year Following Radiofrequency Ablation Of Renal Cortical Tumors
ORLANDO, FL (UroToday.com) - Stern and colleagues report on their experience with tissue biopsy more than 1 year after radiofrequency ablation (RFA) of small renal masses. The study included 19 patients with 20 renal masses (17 pre-treatment proven RCC and 3 oncocytomas) that had previously undergone RFA ablation, were stable in size on follow-up, and showed no evidence of enhancement on imaging.
Source: www.medicalnewstoday.com

Molecular Imaging Sheds New Light On Progression Of Alzheimer's Disease
In the past, physicians were able only to follow the progression of Alzheimer's disease (AD) through careful clinical histories, noting the often subtle changes associated with cognitive decline over a number of years.
Source: www.medicalnewstoday.com

Reform MBS For Patient Benefits, General Practice Week (15-21 June), Australia
The Austalian Medical Association believes the Rudd Government must reform the Medicare Benefit Schedule (MBS) to better rebate patient's access to GPs. The MBS must also be properly indexed, aligned with increasing costs.
Source: www.medicalnewstoday.com

Labels: ,


Subscribe to Posts [Atom]

Home | Order Status | FAQ | Affiliates | Contact us | Newsletter | Refer a Friend

© 2004 Online Pharmacy. All Rights Reserved.